BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21042750)

  • 1. Interaction between nuclear insulin receptor substrate-2 and NF-κB in IGF-1 induces response in breast cancer cells.
    Wu S; Zhou B; Xu L; Sun H
    Oncol Rep; 2010 Dec; 24(6):1541-50. PubMed ID: 21042750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of both insulin receptor substrates 1 and 2 confers increased sensitivity to IGF-1 stimulated cell migration.
    de Blaquière GE; May FE; Westley BR
    Endocr Relat Cancer; 2009 Jun; 16(2):635-47. PubMed ID: 19261680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.
    Knowlden JM; Gee JM; Barrow D; Robertson JF; Ellis IO; Nicholson RI; Hutcheson IR
    Breast Cancer Res; 2011 Sep; 13(5):R93. PubMed ID: 21939528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation.
    Sanmartín-Salinas P; Lobo MDVT; Noguerales-Fraguas F; Londoño MT; Jiménez-Ruiz A; Guijarro LG
    J Gastroenterol; 2018 Aug; 53(8):932-944. PubMed ID: 29353348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17β-estradiol.
    Ye X; Yuan L; Zhang L; Zhao J; Zhang CM; Deng HY
    Asian Pac J Cancer Prev; 2014; 15(12):5001-7. PubMed ID: 24998578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruitment of insulin receptor substrate-1 and activation of NF-kappaB essential for midkine growth signaling through anaplastic lymphoma kinase.
    Kuo AH; Stoica GE; Riegel AT; Wellstein A
    Oncogene; 2007 Feb; 26(6):859-69. PubMed ID: 16878150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway.
    Shao N; Lu Z; Zhang Y; Wang M; Li W; Hu Z; Wang S; Lin Y
    Cancer Lett; 2015 Aug; 364(2):165-72. PubMed ID: 25979232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.
    Tse AK; Zhu GY; Wan CK; Shen XL; Yu ZL; Fong WF
    Mol Immunol; 2010 May; 47(9):1728-38. PubMed ID: 20371119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells.
    Lanzino M; Garofalo C; Morelli C; Le Pera M; Casaburi I; McPhaul MJ; Surmacz E; Andò S; Sisci D
    Breast Cancer Res Treat; 2009 May; 115(2):297-306. PubMed ID: 18521741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells.
    Byron SA; Horwitz KB; Richer JK; Lange CA; Zhang X; Yee D
    Br J Cancer; 2006 Nov; 95(9):1220-8. PubMed ID: 17043687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.
    Ma G; Tabanca N; Husnu Can Baser K; Kirimer N; Pasco DS; Khan IA; Khan SI
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):673-80. PubMed ID: 18597088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin receptor substrate-3, interacting with Bcl-3, enhances p50 NF-kappaB activity.
    Kabuta T; Hakuno F; Cho Y; Yamanaka D; Chida K; Asano T; Wada K; Takahashi S
    Biochem Biophys Res Commun; 2010 Apr; 394(3):697-702. PubMed ID: 20226764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cells.
    Saitoh M; Ohmichi M; Takahashi K; Kawagoe J; Ohta T; Doshida M; Takahashi T; Igarashi H; Mori-Abe A; Du B; Tsutsumi S; Kurachi H
    Endocrinology; 2005 Nov; 146(11):4917-25. PubMed ID: 16123159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence.
    Pratt MA; Bishop TE; White D; Yasvinski G; Ménard M; Niu MY; Clarke R
    Mol Cell Biol; 2003 Oct; 23(19):6887-900. PubMed ID: 12972607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin Receptor Substrate Suppression by the Tyrphostin NT157 Inhibits Responses to Insulin-Like Growth Factor-I and Insulin in Breast Cancer Cells.
    Yang Y; Chan JY; Temiz NA; Yee D
    Horm Cancer; 2018 Dec; 9(6):371-382. PubMed ID: 30229539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
    Gupta V; Yeo G; Kawakubo H; Rangnekar V; Ramaswamy P; Hayashida T; MacLaughlin DT; Donahoe PK; Maheswaran S
    Cancer Res; 2007 Mar; 67(6):2747-56. PubMed ID: 17363596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway.
    Lassarre C; Ricort JM
    Endocrinology; 2003 Nov; 144(11):4811-9. PubMed ID: 12960057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
    Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
    Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.